Skip to main content
Clinical Trials/NCT06109727
NCT06109727
Not yet recruiting
Not Applicable

Acute Effect of tDCS on Motor Performance, Autonomic Control and Attentional and Executive Functions in Young Individuals

Federal University of Rio Grande do Sul1 site in 1 country20 target enrollmentJanuary 1, 2024
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
Federal University of Rio Grande do Sul
Enrollment
20
Locations
1
Primary Endpoint
Effect of tDCS on motor performance
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study is to investigate the effect of transcranial electrical stimulation (tDCS) on motor performance, autonomic control and attentional and executive functions in young individuals.

Detailed Description

Gait research in young and healthy individuals increases knowledge about the neuromuscular structures involved in this motor act and thus helps to develop or adapt therapeutic approaches that increase performance and/ or optimize the rehabilitation process for people with changes in gait control, and patients with neurological diseases. The aim of this study is to investigate the effect of transcranial electrical stimulation (tDCS) on motor performance, autonomic control and attentional and executive functions in young individuals. A total of 20 individuals (10 women and 10 men) aged 20-30 years will participate in this study. Each participant will visit the laboratory on three occasions, interspersed for one week, one visit for the initial evaluation (approximately 1 hour) and two visits for data collection, lasting approximately 1 hour and 40 minutes each. All participants will be randomly allocated in a double-blind and counterbalanced manner in the different experimental conditions. In one of the visits will be composing the intervention group (n=10; 20 min) and in another visit the Sham group (n=10). Outcomes related to motor performance (bilateral coordination, static and dynamic balance and functional mobility), heart rate variability and attentional and executive functions will be evaluated. To this end, the gait will be analyzed through the OpenCap motion analysis system from filming and after, the phase coordination index will be calculated for analysis of bilateral coordination; the stabilometry test will be used to assess the static balance of the participants, using a force platform where the participant remains standing on the platform to measure the center of pressure; functional mobility will be investigated from the 30-second sit-up test, aiming to analyze the dynamic balance and functional strength of the lower body, and the Timed up and Go Test used for balance analysis, gait and functional capacity. Heart rate variability will be recorded from the use of the Polar Vantage heart rate monitor (Finland), with the capacity of the R-R temporal record. The attentional and executive functions will be evaluated from the Stroop Test tool. These are three tasks with 24 items each, where the participant will be evaluated according to how quickly he performs the task and the amount of errors presented. The data will be described as mean. The normality of all data will be verified by the Shapiro-Wilk test. ANOVA with repeated measures of two factors will be used, followed by the Bonferroni post hoc test to compare the variables collected between the different conditions of brain stimulation (with and without application of tDCS) and between gait conditions. One-factor ANOVA will be used for brain stimulation conditions; data will be tabulated via Excel and statistical analyses will be performed in the SPSS software package for Windows version 24.0 (IBM, Chicago, USA). A significant value of p \< 0.05 will be considered.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Federal University of Rio Grande do Sul
Responsible Party
Principal Investigator
Principal Investigator

Taís Malysz

Professora

Federal University of Rio Grande do Sul

Eligibility Criteria

Inclusion Criteria

  • 20-30 years
  • participant of both sex
  • Exclusion criteria:
  • history of neurological or psychological diseases;
  • use of any medications that may affect balance control, such as sedative drugs;
  • presence of skeletal muscle injuries such as fracture, ligament injury, muscle tension or low back pain that restricts movement;
  • presence of any sign of involvement of the spinal cord;
  • visual or hearing impairment;
  • musculoskeletal deformities in the lower or upper extremities that may affect the participant's standing posture;
  • skin conditions (e.g., eczema and injuries) on the scalp

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Effect of tDCS on motor performance

Time Frame: Through study completion, an average of 1 year

* Bilateral coordination of different walking conditions will be assessed by percentage (%) * The static equilibrium will be evaluated by the average amplitude of displacement of the center of pressure in mean lateral and anteroposterior directions (cm)

Secondary Outcomes

  • Effect of tDCS on functional mobility and dynamic balance(Through study completion, an average of 1 year)
  • Efect of tDCS on attentional and executive functions(Through study completion, an average of 1 year)
  • Effect of variability of the heart rate(Through study completion, an average of 1 year)

Study Sites (1)

Loading locations...

Similar Trials